• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Positron puts financial house in order

Article

PET camera developer Positron is close to completing two dealsthat will put the Houston-based company back on firm financialfooting. The deals are intended to solve a cash crunch that hasdogged Positron since last November. In the first piece of the

PET camera developer Positron is close to completing two dealsthat will put the Houston-based company back on firm financialfooting. The deals are intended to solve a cash crunch that hasdogged Positron since last November.

In the first piece of the financial puzzle, Positron has secureda $1 million revolving line of credit with Boston Financial &Equity that allows the vendor to borrow up to 80% of its accountsreceivables. The financing will give Positron short-term creditflexibility and will enable the company to finance the constructionof PET scanners as it fulfills customer orders, according to CFODavid Rodrigue.

In addition, Positron plans to place up to 2.3 million sharesof preferred stock with private investors. The company hopes toraise between $2 million and $3.5 million with the offering.

Positron will use the funds for working capital and to bringthe company back into compliance with listing requirements forNASDAQ's national market system. Positron has fallen below NASDAQ's$4 million minimum net worth requirement and its stock will bemoved to NASDAQ's small cap market unless it raises more funds.

Recent Videos
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.